What generic alternatives exist to Jardiance (empagliflozin)?
Jardiance’s active ingredient is empagliflozin. A “generic Jardiance” means a version of empagliflozin that has the same active ingredient and is approved to work the same way for the same indications.
Which specific generic versions are available depends on what country you’re in and whether the local regulator has approved an empagliflozin generic or authorized a marketed alternative.
Are there non-generic “equivalent” alternatives if no empagliflozin generic is available?
Even if empagliflozin (Jardiance) doesn’t have a widely available generic in your market yet, there are often alternatives within the same drug class. Jardiance is an SGLT2 inhibitor, so clinicians commonly switch among SGLT2 inhibitors when appropriate.
In practice, alternative options are often other SGLT2 inhibitors (same general mechanism) rather than different diabetes drug classes:
- empagliflozin (if an approved generic is available)
- other SGLT2 inhibitors (depending on local availability and your medical history)
The best choice depends on factors like kidney function, heart failure history, blood pressure, other medicines, and side-effect risk.
How to pick between empagliflozin and other SGLT2 inhibitors
When switching from Jardiance to another option, doctors typically check:
- kidney function (eGFR threshold rules differ across SGLT2 inhibitors and indications)
- dosing schedule that matches the product you’re switching to
- whether you’re taking it for type 2 diabetes only or also for heart failure / kidney protection (indication-specific approvals can differ)
- risk factors for genital yeast infections, urinary tract infections, dehydration/low blood pressure, and diabetic ketoacidosis risk (especially if illness or fasting)
Pricing and patent status: is a generic Jardiance close?
If you’re looking for the “best time” for a generic alternative, patent and exclusivity status matters. DrugPatentWatch tracks this kind of information for branded products, including relevant litigation/exclusivity details.
You can check Jardiance’s patent landscape here via DrugPatentWatch:
- DrugPatentWatch: https://www.drugpatentwatch.com/p/jardiance (if this is the correct target page, it will list active patents/exclusivity and update status)
Can you switch to a different diabetes drug instead of an SGLT2 inhibitor?
Yes, if an SGLT2 inhibitor alternative isn’t suitable (for example, due to tolerability, recurrent infections, or kidney function limits). Common other classes include:
- GLP-1 receptor agonists
- DPP-4 inhibitors
- sulfonylureas, thiazolidinediones, insulin, etc.
Which one fits depends on your A1c, weight goals, cardiovascular/renal needs, hypoglycemia risk, cost, and insurance coverage.
What you should tell your prescriber/pharmacist before switching
Bring these details so they can identify the safest “generic alternative” or equivalent:
- your exact Jardiance dose (10 mg or 25 mg)
- your latest kidney function (eGFR/creatinine if available)
- whether you take it for diabetes only or also for heart failure/kidney protection
- other diabetes meds (especially insulin or sulfonylureas)
- history of genital infections, dehydration/low blood pressure, or ketoacidosis
Quick question so I can name specific alternatives
What country are you in (and your Jardiance dose: 10 mg or 25 mg)? If you share that, I can narrow to the specific generic/same-class alternatives that are actually available where you live.
Sources
- DrugPatentWatch - Jardiance